Geographic reach Amarin operates with a direct U.S. sales force and an international distribution network spanning over 90 markets, indicating strong global commercial capabilities and potential for partnerships to expand Vascepa or future CV therapeutic lines.

Cardiovascular focus The company is devoted to reducing the cardiovascular disease burden with a proven, safety-backed product portfolio, presenting continual cross-sell opportunities in hospitals, clinics, and payer programs seeking robust CV solutions.

Financial health Current revenue range and growth signals, including a recent Q1 uptick driven by steady Vascepa performance and licensing revenue, suggest a scalable, license/royalty-friendly model favorable for co-development or co-promotion agreements.

Strategic leadership Board appointments and leadership moves, plus ongoing litigation dynamics around IP, point to opportunities for advisory partnerships, strategic investments, or diligence-focused engagements with key decision-makers.

Digital and tech readiness Adoption of established tech stack and digital infrastructure (SiteCatalyst, Cloudflare, Google Tag Manager) indicates readiness for digital marketing collaborations, data-driven regional marketing programs, and analytics-driven market entry strategies.